Skip to content
value.today

DeliverCareRX, Inc.

🇺🇸 Charlotte, North Carolina, USAPharmaceuticalsFounded 2012
Total raised
$10 M
1 round on record
Latest round
$10 M
Nov 2015
First round on record
Nov 2015
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of DeliverCareRX, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2015$10 MNo. 1$10 to $50 million

DeliverCareRX, Inc.: Raise no. 1, Nov 2015

Investors in this round

4 investors had bought by the notice of Nov 10, 2015: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $14 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dave Krishna · Executive Officer
  • Tobe Cohen · Executive Officer
  • Bruce Failing · Director
  • Harry Rein · Director
  • Michael Persky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “No payments other than ordinary course employment compensation is being paid to officers or directors.”

Signed by Dave Krishna, Chief Operating Officer & Vice President. Source: SEC Form D, newest notice filed Nov 10, 2015. Read the notice at the SEC.

equitySEC
Oct 2012$2 MIssued in a merger or acquisition$2 to $10 million

DeliverCareRX, Inc.: Private sale, Oct 2012

Investors in this round

12 investors had bought by the notice of Nov 9, 2012: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$112,500 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sayles Braga · Executive Officer, Director
  • Steve Purdy · Executive Officer, Director
  • Bruce Failing · Director
  • Michael Persky · Director
  • David Silver · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “A portion of the offering was made in connection with a merger.”

Signed by Steve Purdy, President. Source: SEC Form D, newest notice filed Nov 9, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • DeliverCareRX, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2015).

    SEC Form D · Nov 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Nov 2015

That is all the official record says: DeliverCareRX, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of DeliverCareRX, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by DeliverCareRX, Inc.
NameRoleNamed in
Dave KrishnaExecutive officerNov 2015
Tobe CohenExecutive officerNov 2015
Sayles BragaExecutive officerNov 2012
Steve PurdyExecutive officerNov 2012
Bruce FailingDirectorNov 2015
Harry ReinDirectorNov 2015
Michael PerskyDirectorNov 2015
Sayles BragaDirectorNov 2012
Steve PurdyDirectorNov 2012
David SilverPromoterNov 2012